By Rob Sutter


When it comes to the field of medical research, any kind of information is going to have my attention. However, how much attention is given to the actions being done outside of the United States? I think that great work is being done in this regard, though I'd like to place my focus on glioblastoma research for the time being. Bevacizumab is definitely on the mind and, whether you realize it or not, this potentially unfamiliar term may just make strides in the way of therapy soon enough.

What is the reason for this tumor being looked at compared to others? I think that it has to do with the fact that glioma is the most prevalent in the world, not only potentially located in the brain but the spinal column as well. This type, which accounts for 80% of all malignant variations, is one that has not always been effectively removed via surgery. With work being done to help the problem, though, you can rest assured that tireless efforts are common.

Medscape posted a report, saying how glioblastoma research would be assisted thanks to the Japanese Military of Health, Labor, and Welfare and the usage of bevacizumab. Cases which have deemed malignant would be helped and this would be done with the usage of chemo along with radiation. For those who are curious, this was not the first time that this process has been followed through. You may just learn from authorities along the lines of V.A.B.C. that there have been some varying results in the past, which should be talked about also.

Keep in mind that bevacizumab has been approved in the United States but not for new patients. Rather, the article stated that it was utilized in order to assist those with recurrent cases. However, there have been concerns about the method and how it wouldn't be able to help patients. A meeting at the annual American Society of Clinical Oncology stated that there wasn't a clear benefit, though it seems like this is still being focused on, which gives me hope that there is still potential.

My only hope is that findings are far more prevalent because of the news at hand. I know that glioblastoma research is a noble endeavor to go about and the level of work which is seen is, in my eyes, some of the best. However, I think that more facts should be put to use and I think that various therapies can make certain of this. Hopefully the results in question can be put to use so that, in the future, therapies can become much more effective.




About the Author:



0 comments:

Post a Comment

top